Introduction Over 350 000 sacral neuromodulation (SNM) devices have been implanted
since approval by the Food and Drug Administration (FDA) in 1998. SNM technology and …

Neuromodulation for bladder dysfunction symptoms has been an important addition to the
armamentarium of urologists in the last decade. Pelvic health specialists are interested in …

Purpose We quantified patient record documentation of sacral neuromodulation (SNM)
threshold testing and programming parameters at our institution to identify opportunities to …

Objective In this study, we analyzed claims data from the Ingenix data base to analyze
outcomes of sacral neuromodulation with respect to both provider and patient factors …

METHODS Current Canadian Urological Association members were invited to participate in
an anonymous survey. Data collected included open-ended and Likert scale responses …

Introduction The InSite trial is a prospective, multicenter study of sacral neuromodulation
(SNM) therapy with the InterStim® System in subjects with overactive bladder (OAB). One of …

Abstract Purpose of Review Sacral neuromodulation (SNM) is being used to treat lower
urinary tract symptoms (LUTS) with growing popularity among clinicians in multiple …

Aims Sacral neuromodulation (SNM) is a minimally invasive technique that provides
effective treatment for the management of refractory overactive bladder (OAB), non …

Aim To describe factors associated with satisfaction with the Axonics sacral
neuromodulation (SNM) System at 1 year. Methods This was a secondary analysis of data …

Aims Sacral neuromodulation (SNM) is an accepted therapy for a variety of conditions.
However, despite over 20 years of experience, it remains a specialized procedure with a …